Pixelgen Technologies
High-throughput platform mapping molecular cell architecture at nanoscale resolution
$15.5MSeries B
Role not disclosedLoading investors…
Activity from announced rounds
High-throughput platform mapping molecular cell architecture at nanoscale resolution
Provides technology-driven patient recruitment for clinical trials